Conflictos en ética de investigación con seres humanos
Autor(a) principal: | |
---|---|
Data de Publicação: | 2005 |
Tipo de documento: | Artigo |
Idioma: | spa |
Título da fonte: | Cadernos de Saúde Pública |
Texto Completo: | https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2432 |
Resumo: | The Declaration of Helsinki (2000) helped trigger a major debate on many ethical aspects of research with human subjects. Topics under discussion include the use of placebos, the application of equipoise, the distinction between research ethics and clinical ethics, and the difference between therapeutic and non-therapeutic trials. This article supports tenets that serve to protect patients involved in research, especially in those aspects concerning maintenance of best existing therapy, the rejection of using placebos, support of equipoise, the assurance that required medication shall be available beyond the termination of the research project, and that appropriate compensation will obtain to host communities inasmuch as they may have facilitated and supported the project. The current proposal of introducing a double ethical standard, aspirational for developed countries and pragmatic for poor nations, should be rejected, since it contravenes the universalizability of prescriptive ethics. |
id |
FIOCRUZ-5_8978fa3f219e6252d05431e4d18c002f |
---|---|
oai_identifier_str |
oai:ojs.teste-cadernos.ensp.fiocruz.br:article/2432 |
network_acronym_str |
FIOCRUZ-5 |
network_name_str |
Cadernos de Saúde Pública |
repository_id_str |
|
spelling |
Conflictos en ética de investigación con seres humanosÉtica en InvestigaciónDeclaración de HelsinkiPlacebosThe Declaration of Helsinki (2000) helped trigger a major debate on many ethical aspects of research with human subjects. Topics under discussion include the use of placebos, the application of equipoise, the distinction between research ethics and clinical ethics, and the difference between therapeutic and non-therapeutic trials. This article supports tenets that serve to protect patients involved in research, especially in those aspects concerning maintenance of best existing therapy, the rejection of using placebos, support of equipoise, the assurance that required medication shall be available beyond the termination of the research project, and that appropriate compensation will obtain to host communities inasmuch as they may have facilitated and supported the project. The current proposal of introducing a double ethical standard, aspirational for developed countries and pragmatic for poor nations, should be rejected, since it contravenes the universalizability of prescriptive ethics.Desde la Declaración de Helsinki 2000, se intensificó y amplió un conflictivo debate que ha cuestionado muchos aspectos de la ética de investigación con seres humanos. La polémica incluye el uso de placebos, la aplicación del concepto de equiponderación, la distinción entre ética de investigación y ética clínica, así como la diferencia entre ensayos terapéuticos y no terapéuticos. El presente artículo insiste en fortalecer todos los argumentos, parámetros y estrategias de investigación que sean necesarios para proteger a los paciente-probandos, ante todo el mantenimiento de la mejor terapia existente, el rechazo del uso de placebos, la aplicación de la equiponderación, la preservación de requerimientos terapéuticos más allá del estudio y la compensación a comunidades-huésped en la medida que ellas hayan facilitado y apoyado la investigación. La propuesta de establecer un doble estándar de ética de investigación en seres humanos, una de máximos para países desarrollados y otra de mínimos pragmáticos a aplicar en países de desarrollo precario, debe ser rechazada por contravenir las intenciones de universalizabilidad de toda prescripción ética.Reports in Public HealthCadernos de Saúde Pública2005-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlapplication/pdfhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2432Reports in Public Health; Vol. 21 No. 3 (2005): May/JuneCadernos de Saúde Pública; v. 21 n. 3 (2005): Maio/Junho1678-44640102-311Xreponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZspahttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2432/4868https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2432/4869Kottow, Miguel H.info:eu-repo/semantics/openAccess2024-03-06T15:27:02Zoai:ojs.teste-cadernos.ensp.fiocruz.br:article/2432Revistahttps://cadernos.ensp.fiocruz.br/ojs/index.php/csphttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/oaicadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2024-03-06T13:02:50.806216Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)true |
dc.title.none.fl_str_mv |
Conflictos en ética de investigación con seres humanos |
title |
Conflictos en ética de investigación con seres humanos |
spellingShingle |
Conflictos en ética de investigación con seres humanos Kottow, Miguel H. Ética en Investigación Declaración de Helsinki Placebos |
title_short |
Conflictos en ética de investigación con seres humanos |
title_full |
Conflictos en ética de investigación con seres humanos |
title_fullStr |
Conflictos en ética de investigación con seres humanos |
title_full_unstemmed |
Conflictos en ética de investigación con seres humanos |
title_sort |
Conflictos en ética de investigación con seres humanos |
author |
Kottow, Miguel H. |
author_facet |
Kottow, Miguel H. |
author_role |
author |
dc.contributor.author.fl_str_mv |
Kottow, Miguel H. |
dc.subject.por.fl_str_mv |
Ética en Investigación Declaración de Helsinki Placebos |
topic |
Ética en Investigación Declaración de Helsinki Placebos |
description |
The Declaration of Helsinki (2000) helped trigger a major debate on many ethical aspects of research with human subjects. Topics under discussion include the use of placebos, the application of equipoise, the distinction between research ethics and clinical ethics, and the difference between therapeutic and non-therapeutic trials. This article supports tenets that serve to protect patients involved in research, especially in those aspects concerning maintenance of best existing therapy, the rejection of using placebos, support of equipoise, the assurance that required medication shall be available beyond the termination of the research project, and that appropriate compensation will obtain to host communities inasmuch as they may have facilitated and supported the project. The current proposal of introducing a double ethical standard, aspirational for developed countries and pragmatic for poor nations, should be rejected, since it contravenes the universalizability of prescriptive ethics. |
publishDate |
2005 |
dc.date.none.fl_str_mv |
2005-06-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2432 |
url |
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2432 |
dc.language.iso.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2432/4868 https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2432/4869 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html application/pdf |
dc.publisher.none.fl_str_mv |
Reports in Public Health Cadernos de Saúde Pública |
publisher.none.fl_str_mv |
Reports in Public Health Cadernos de Saúde Pública |
dc.source.none.fl_str_mv |
Reports in Public Health; Vol. 21 No. 3 (2005): May/June Cadernos de Saúde Pública; v. 21 n. 3 (2005): Maio/Junho 1678-4464 0102-311X reponame:Cadernos de Saúde Pública instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Cadernos de Saúde Pública |
collection |
Cadernos de Saúde Pública |
repository.name.fl_str_mv |
Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br |
_version_ |
1821325497231998976 |